COVAX Will Be Able To Give Country Data On Expected COVID Vaccine Allocations Within ‘Next Day’ 29/01/2021 Kerry Cullinan Member countries will have an idea of how many COVID vaccine doses they will receive via the World Health Organization’s COVAX Facility and when they will arrive within the next day, WHO special advisor Dr Bruce Alyward has said. These “indicative allocations” would depend on when the WHO’s regulatory review of the specific vaccines that […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> WHO Executive Board Rejects Israel’s Proposal To Remove Standalone Agenda Item On Palestinian Health Conditions 28/01/2021 Madeleine Hoecklin For the second time in as many years, WHO member states have voted down a proposal by Israel to remove a standalone item from the agenda of the 74th World Health Assembly – devoted exclusively to a report on health conditions in the Occupied Palestinian territories – and consider it as part of WHO’s overall […] Continue reading -> EU Protests AstraZeneca Vaccine Delays – Could Block UK-Bound Exports 28/01/2021 Madeleine Hoecklin AstraZeneca has joined Pfizer in announcing delays in deliveries of COVID-19 vaccines to countries in Europe, leading furious EU officials to plan for a system of tighter monitoring of vaccine exports. The British-Swedish pharma company that developed its COVID-19 vaccine with researchers at Oxford University, informed the European Commission on Friday that there would be […] Continue reading -> Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies 27/01/2021 Paul Adepoju & Svĕt Lustig Vijay While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> WHO Executive Board Rejects Israel’s Proposal To Remove Standalone Agenda Item On Palestinian Health Conditions 28/01/2021 Madeleine Hoecklin For the second time in as many years, WHO member states have voted down a proposal by Israel to remove a standalone item from the agenda of the 74th World Health Assembly – devoted exclusively to a report on health conditions in the Occupied Palestinian territories – and consider it as part of WHO’s overall […] Continue reading -> EU Protests AstraZeneca Vaccine Delays – Could Block UK-Bound Exports 28/01/2021 Madeleine Hoecklin AstraZeneca has joined Pfizer in announcing delays in deliveries of COVID-19 vaccines to countries in Europe, leading furious EU officials to plan for a system of tighter monitoring of vaccine exports. The British-Swedish pharma company that developed its COVID-19 vaccine with researchers at Oxford University, informed the European Commission on Friday that there would be […] Continue reading -> Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies 27/01/2021 Paul Adepoju & Svĕt Lustig Vijay While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
WHO Executive Board Rejects Israel’s Proposal To Remove Standalone Agenda Item On Palestinian Health Conditions 28/01/2021 Madeleine Hoecklin For the second time in as many years, WHO member states have voted down a proposal by Israel to remove a standalone item from the agenda of the 74th World Health Assembly – devoted exclusively to a report on health conditions in the Occupied Palestinian territories – and consider it as part of WHO’s overall […] Continue reading -> EU Protests AstraZeneca Vaccine Delays – Could Block UK-Bound Exports 28/01/2021 Madeleine Hoecklin AstraZeneca has joined Pfizer in announcing delays in deliveries of COVID-19 vaccines to countries in Europe, leading furious EU officials to plan for a system of tighter monitoring of vaccine exports. The British-Swedish pharma company that developed its COVID-19 vaccine with researchers at Oxford University, informed the European Commission on Friday that there would be […] Continue reading -> Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies 27/01/2021 Paul Adepoju & Svĕt Lustig Vijay While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
EU Protests AstraZeneca Vaccine Delays – Could Block UK-Bound Exports 28/01/2021 Madeleine Hoecklin AstraZeneca has joined Pfizer in announcing delays in deliveries of COVID-19 vaccines to countries in Europe, leading furious EU officials to plan for a system of tighter monitoring of vaccine exports. The British-Swedish pharma company that developed its COVID-19 vaccine with researchers at Oxford University, informed the European Commission on Friday that there would be […] Continue reading -> Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies 27/01/2021 Paul Adepoju & Svĕt Lustig Vijay While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies 27/01/2021 Paul Adepoju & Svĕt Lustig Vijay While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts